F
Frances C. Wright
Researcher at Sunnybrook Health Sciences Centre
Publications - 224
Citations - 7224
Frances C. Wright is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 35, co-authored 195 publications receiving 5835 citations. Previous affiliations of Frances C. Wright include University of Toronto & Women's College, Kolkata.
Papers
More filters
Journal ArticleDOI
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries,John F. Thompson,Alistair J. Cochran,Robert H.I. Andtbacka,Nicola Mozzillo,Jonathan S. Zager,Tiina Jahkola,Tawnya L. Bowles,Alessandro Testori,Peter D. Beitsch,Harald J. Hoekstra,Marc Moncrieff,Christian Ingvar,Michel W.J.M. Wouters,Michael S. Sabel,Edward A. Levine,Doreen M. Agnese,Michael A. Henderson,Reinhard Dummer,Carlo Riccardo Rossi,Rogerio I. Neves,Steven D. Trocha,Frances C. Wright,David R. Byrd,Maurice Matter,Eddy Hsueh,Alastair MacKenzie-Ross,Douglas B. Johnson,Patrick Terheyden,Adam C. Berger,Tara L. Huston,Jeffrey D. Wayne,B. Mark Smithers,Heather B. Neuman,Schlomo Schneebaum,Jeffrey E. Gershenwald,Charlotte E. Ariyan,Darius C. Desai,Lisa K. Jacobs,Kelly M. McMasters,Anja Gesierich,Peter Hersey,Steven D. Bines,John M. Kane,Richard J. Barth,Gregory McKinnon,Jeffrey M. Farma,Erwin S. Schultz,Sergi Vidal-Sicart,Richard A. Hoefer,James M. Lewis,Randall P. Scheri,Mark C. Kelley,Omgo E. Nieweg,R. Dirk Noyes,Dave S.B. Hoon,He-Jing Wang,David Elashoff,Robert Elashoff +58 more
TL;DR: Immediate completion lymph‐node dissection increased the rate of regional disease control and provided prognostic information but did not increase melanoma‐specific survival among patients with melanoma and sentinel‐node metastases.
Journal Article
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes : dose adjustment for normal eating (DAFNE) randomised controlled trial
Stephanie A. Amiel,Sue Beveridge,Clare Bradley,Carla Gianfrancesco,Simon Heller,Peter W. James,Natalie McKeown,Douglas P. Newton,Lynn D. Newton,Lindsay Oliver,Helen Reid,Susan B. Roberts,Sue Robson,Jackie Rollingson,Val Scott,Jane Speight,Carolin Taylor,G. Thompson,Eileen Turner,Frances C. Wright +19 more
TL;DR: Skills training promoting dietary freedom improved quality of life and glycaemic control in people with type 1 diabetes without worsening severe hypoglycaemia or cardiovascular risk.
Journal ArticleDOI
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Jean-Francois Boileau,Brigitte Poirier,Mark Basik,Claire M. B. Holloway,Louis Gaboury,Lucas Sideris,Sarkis Meterissian,Angel Arnaout,Muriel Brackstone,David R. McCready,Stephen E. Karp,Isabelle Trop,Andre Lisbona,Frances C. Wright,Rami Younan,Louise Provencher,Erica Patocskai,Atilla Omeroglu,André Robidoux +18 more
TL;DR: It is recommended that SN evaluation with IHC be further evaluated before being included in future guidelines on the use of SNB after NAC in this setting, and a low SNB FNR (8.4%) can be achieved with mandatory use of IHC.
Journal ArticleDOI
Multidisciplinary cancer conferences: A systematic review and development of practice standards
TL;DR: The process of creating an Ontario MCC standards document is described, including a literature review and an examination of the attitudes of Ontario practitioners and hospital administrators regarding the development and implementation of a MCC Standards document.
Journal ArticleDOI
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging
Ellen Warner,Kimberley Hill,Petrina A. Causer,Donald B. Plewes,Roberta A. Jong,Martin J. Yaffe,William D. Foulkes,Parviz Ghadirian,Henry T. Lynch,Fergus J. Couch,John Wong,Frances C. Wright,Ping Sun,Steven A. Narod +13 more
TL;DR: Annual surveillance with MRI is associated with a significant reduction in the incidence of advanced-stage breast cancer in BRCA1 and BRCa2 carriers.